GlassScriptPhysician profile
Raj Raval
NPI 1851682496
$4,901.78
in general payments reported to CMS, 2019-2025
8 companies · $721 in 2025
The $721 reported for 2025 was more than what 84% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,446 · 2020: $219 · 2021: $382 · 2022: $416 · 2023: $697 · 2024: $1,021 · 2025: $721.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,423 · Travel and Lodging: $15.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,423.32 |
| Travel and Lodging | $15.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,967.49 | 2019-2023 | Senza |
| Boston Scientific Corporation | $1,432.45 | 2022-2025 | General - Pain Management, General - Therapies, Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $870.01 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Rialto Si Fusion System |
| Abbott Laboratories | $328.93 | 2021-2024 | Eterna, Proclaim |
| Medtronic USA, INC. | $170.59 | 2020 | |
| Biogen, INC. | $57.75 | 2021 | |
| Kci USA, INC. | $48.83 | 2020 | |
| Palette Life Sciences, INC. | $25.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raj Raval listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.